Pro Research: Wall Street eyes Visa’s growth and resilience By Investing.com
[ad_1] Explore Wall Street’s expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon. Dive deeper into the financial world...
Pro Research: Wall Street delves into Vertex Pharmaceuticals By Investing.com
[ad_1] Explore Wall Street’s expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon. Dive deeper into the financial world...
Pro Research: Wall Street eyes Walmart’s strategic moves By Investing.com
[ad_1] Company Overview Walmart Inc. (NYSE:), the multinational retail giant, remains at the forefront of the retail industry with its extensive array of hypermarkets, discount...
Pro Research: Wall Street dives into Zscaler’s strategic position By Investing.com
[ad_1] Zscaler Inc . (NASDAQ:) Financial Analysis Update In light of recent financial analyses, Zscaler Inc. has demonstrated a complex yet promising landscape in the...
Acm research director sells over $538k in company stock By Investing.com
[ad_1] © Reuters. In a recent transaction, Haiping Dun, a director at ACM Research, Inc. (NASDAQ:), sold a significant number of shares in the company....
Acm research executive sells over $280k in company stock By Investing.com
[ad_1] © Reuters. An executive at ACM Research, Inc. (NASDAQ:), a leading provider of wafer processing solutions for semiconductor manufacturing, has recently sold a significant...
ACM Research executive David Wang sells over $2.4m in company stock By Investing.com
[ad_1] © Reuters. In a recent transaction, David H. Wang, the Chief Executive Officer, President, and Director of ACM Research, Inc. (NASDAQ:), has sold a...
Wolfe Research maintains $2,850 stock target on Chipotle shares By Investing.com
[ad_1] © Reuters. On Tuesday, Wolfe Research reaffirmed its positive stance on Chipotle Mexican Grill (NYSE:), maintaining an Outperform rating with a stock price target...
CalciMedica stock target raised to $9.50 by Singular Research amid new fund By Investing.com
[ad_1] © Reuters. On Monday, Singular Research adjusted its outlook on CalciMedica (NASDAQ:CALC), a biopharmaceutical company, raising the price target to $9.50 from the previous...
Wolfe Research begins coverage on biotech, names Alpine Immune Sciences as Top Pick By Investing.com
[ad_1] © Reuters. Wolfe Research begins coverage on biotech, names Alpine Immune Sciences as Top Pick Wolfe Research has initiated coverage on the biotechnology sector,...